![Philip Herman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philip Herman
Corporate Officer/Principal presso
PMV PHARMACEUTICALS, INC.
Profilo
Philip Karl Herman is Chief Commercial Officer at PMV Pharmaceuticals, Inc. since 2026.
Formerly, Mr. Herman was EVP, Chief Commercial & Portfolio Development at Repare Therapeutics, Inc. from 2022 to 2026; Chief Commercial Officer & Senior Vice President at Y-mAbs Therapeutics, Inc. from 2018 to 2021; Vice President at Santhera Pharmaceuticals (USA), Inc. from 2016 to 2018; Vice President, Head-Commercial & Marketing at Dyax Corp.
from 2015 to 2016; and Marketing Director at Vanda Pharmaceuticals, Inc. from 2013 to 2015.
Education includes an MBA from Kellogg School of Management and an undergraduate degree from Baldwin Wallace University School of Business.
Posizioni attive di Philip Herman
| Società | Posizione | Inizio |
|---|---|---|
| PMV PHARMACEUTICALS, INC. | Corporate Officer/Principal | 08/09/2026 |
Precedenti posizioni note di Philip Herman
| Società | Posizione | Fine |
|---|---|---|
| REPARE THERAPEUTICS INC. | Corporate Officer/Principal | 28/01/2026 |
| YMAS THER | Corporate Officer/Principal | 31/12/2021 |
Santhera Pharmaceuticals (USA), Inc.
 Santhera Pharmaceuticals (USA), Inc. Pharmaceuticals: MajorHealth Technology Develops and wholesales medicines for other diseases with high unmet medical needs | Corporate Officer/Principal | 01/05/2018 |
| DYAX CORP. | Vendite & Marketing | 01/01/2016 |
| VANDA PHARMACEUTICALS INC. | Vendite & Marketing | 01/03/2015 |
Formazione di Philip Herman
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
45
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Dyax Corp.
 Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics | Health Technology |
Vanda Pharmaceuticals, Inc.
 Vanda Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company, which focuses on the development and commercialization of therapies | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PMV Pharmaceuticals, Inc.
 PMV Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in discovery and development of small molecule, tumor-agnostic therapies targeting p53 | Health Technology |
Y-mAbs Therapeutics, Inc.
 Y-mAbs Therapeutics, Inc. BiotechnologyHealth Technology Develops radioimmunotherapy and antibody-based oncology therapies for treating cancer | Health Technology |
Repare Therapeutics, Inc.
 Repare Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel cancer therapies | Health Technology |
Santhera Pharmaceuticals (USA), Inc.
Santhera Pharmaceuticals (USA), Inc. Pharmaceuticals: MajorHealth Technology Develops and wholesales medicines for other diseases with high unmet medical needs | Health Technology |
Baldwin Wallace University School of Business
 Baldwin Wallace University School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
